美国不同地区卵胞浆内单精子注射利用的时间差异
该回顾性队列研究利用美国疾病控制与预防中心2000-2014年数据,分析不同地区卵胞浆内单精子注射(ICSI)的使用、指征和结局。全国ICSI使用率增加52%,但妊娠率和活产率仅分别增加8.5%和7.6%,ICSI使用与男性因素诊断无相关性,提示ICSI可能被过度使用。
要点
- 2000至2014年全国ICSI使用率增加52%(46.3±6.1%至70.0±7.1%)。
- 每周期妊娠率和活产率分别仅增加8.5%和7.6%,与ICSI率呈正相关。
- ICSI使用增加与男性因素诊断增加不相关,提示可能过度使用。
核心结论
- 2000至2014年,每诊所ICSI率在不同地理区域间存在显著差异,ICSI使用增加与男性因素诊断增加不相关,这些发现提示ICSI可能被过度使用,因其使用未伴随医学指征或有效性的相应增加。
研究设计与样本
- 回顾性队列研究,数据来自美国疾病控制与预防中心2000-2014年数据集,纳入每年至少100个新鲜非供卵周期的诊所,按10个卫生与公众服务部(DHHS)认可区域分组,比较小于35岁女性新鲜体外受精周期中ICSI使用、男性因素不孕频率、植入前遗传学治疗、妊娠率和活产率。
主要发现
- 全国ICSI使用率从2000年的46.3±6.1%增至2014年的70.0±7.1%,增加52%。
- 每周期妊娠率从39.2±3.8%增至42.5±2.5%,增加8.5%;活产率从34.4±3.6%增至37±2.6%,增加7.6%。
- 每诊所ICSI率与妊娠率(r=0.78,P<.001)和活产率(r=0.76,P=.001)呈正相关。
- 所有DHHS区域ICSI使用率均随时间增加,但增加幅度因地区而异。
- 2000至2010年(r=0.32,P=.33)和2011至2014年(r=0.85,P=.068),每诊所男性因素与ICSI率无相关性;2007至2014年ICSI与植入前遗传学检测无强相关性(r=0.68,P=.062)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze changes in intracytoplasmic sperm injection (ICSI) utilization, indications, and outcomes across U.S. regions. METHODS: We conducted a retrospective cohort study. Data sets for 2000-2014 were obtained from the Centers for Disease Control and Prevention. Clinics with 100 or greater fresh, nondonor cycles were grouped by 10 nationally recognized Department of Health and Human Services (DHHS) regions and were compared for use of ICSI, frequency of male factor infertility, preimplantation genetic therapies, pregnancy, and live birth rates per cycle among fresh in vitro fertilization cycles in women younger than 35 years of age. RESULTS: Nationwide ICSI utilization increased 52% (46.3±6.1% to 70.0±7.1%) from 2000 to 2014, whereas pregnancy and live birth rates per cycle modestly increased by 8.5% (39.2±3.8% to 42.5±2.5%) and 7.6% (34.4±3.6% to 37±2.6%), respectively, showing a positive correlation (r=0.78, P<.001; r=0.76, P=.001) with ICSI rates per clinic. All DHHS Services regions demonstrated increases in ICSI utilization over time, although the magnitude of increase varied in different regions. Regions also had similarities in trends for pregnancy and live birth rates per cycle in women younger than 35 years. There was no correlation between male factor and ICSI rates per clinic from 2000 to 2010 (r=0.32, P=.33) or 2011 to 2014 (r=0.85, P=.068). From 2007 to 2014, ICSI and preimplantation genetic testing did not demonstrate a strong correlation (r=0.68, P=.062). CONCLUSION: From 2000 to 2014, ICSI rates per clinic significantly varied among geographic regions. Increased use of ICSI did not correlate with an increase in male factor diagnoses. These findings suggest that ICSI may be overused, because its use is not accompanied by proportionate increases in medical indications or effectiveness.
引用
- Zagadailov P, Hsu A, Stern JE, et al. Temporal Differences in Utilization of Intracytoplasmic Sperm Injection Among U.S. Regions. Obstet Gynecol. 2018. PMID: 29995722. doi:10.1097/AOG.0000000000002730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。